Uncategorized

Finasteride Market is experiencing increased regulatory attention after the U.S. Food and Drug Administration (FDA) issued a safety alert on April 22, 2025, highlighting potential risks associated with compounded topical finasteride formulations. This development has raised concerns across the healthcare and pharmaceutical sectors, particularly as demand for hair loss treatments continues to rise globally. Finasteride,

Fenofibrate Market is undergoing a significant transition following a major regulatory development from the U.S. Food and Drug Administration (FDA), which has revised the labeling for fenofibrate drugs to clearly state a lack of cardiovascular (CV) benefit. Announced on October 27, 2025, in Dublin and Bridgewater, New Jersey, the update was supported by Amarin Corporation

Fluconazole Market continues to strengthen its global footprint as FDC Limited announced on January 9, 2026, that it has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fluconazole Tablets USP. The approval covers four dosage strengths—50 mg, 100 mg, 150 mg, and 200 mg—marking a

Canada-based Eurofins CDMO Alphora has announced a significant advancement in its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the integration of advanced Continuous Flow (CF) technology. The development, announced on April 16, 2026, highlights the company’s focus on innovation, efficiency, and sustainable pharmaceutical production.   Enhancing API Manufacturing with Continuous Flow Technology The integration of

Zydus Lifesciences Limited announced an extension in the timeline for completing the acquisition of the Active Pharmaceutical Ingredient (API) business of Sterling Biotech Limited, reinforcing its strategy to strengthen API manufacturing capabilities.   Expanding API Manufacturing Portfolio The proposed acquisition involves the transfer of Sterling Biotech’s API business assets, which include manufacturing infrastructure and product